IRIS
RIGAMONTI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.560
EU - Europa 3.897
AS - Asia 2.662
SA - Sud America 527
Continente sconosciuto - Info sul continente non disponibili 210
AF - Africa 119
OC - Oceania 14
Totale 11.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.329
RU - Federazione Russa 1.059
SG - Singapore 801
IE - Irlanda 751
IT - Italia 660
CN - Cina 470
VN - Vietnam 406
BR - Brasile 375
HK - Hong Kong 355
DE - Germania 318
SE - Svezia 293
FR - Francia 201
UA - Ucraina 187
IN - India 140
GB - Regno Unito 138
CA - Canada 133
BD - Bangladesh 88
FI - Finlandia 84
KR - Corea 77
ID - Indonesia 73
AR - Argentina 54
NL - Olanda 43
TR - Turchia 42
JP - Giappone 34
MX - Messico 34
BJ - Benin 32
ZA - Sudafrica 32
ES - Italia 29
IR - Iran 29
IQ - Iraq 28
PK - Pakistan 28
AT - Austria 27
PL - Polonia 26
EC - Ecuador 25
CL - Cile 22
CZ - Repubblica Ceca 22
MY - Malesia 20
AU - Australia 14
VE - Venezuela 14
TH - Thailandia 13
PY - Paraguay 12
CO - Colombia 11
PE - Perù 11
CR - Costa Rica 10
HN - Honduras 10
TW - Taiwan 10
CH - Svizzera 9
EG - Egitto 9
LT - Lituania 9
KE - Kenya 8
MA - Marocco 8
PH - Filippine 8
TT - Trinidad e Tobago 8
BE - Belgio 7
GT - Guatemala 7
IL - Israele 7
JM - Giamaica 7
NG - Nigeria 7
RO - Romania 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
DZ - Algeria 4
EE - Estonia 4
MO - Macao, regione amministrativa speciale della Cina 4
PR - Porto Rico 4
PT - Portogallo 4
SA - Arabia Saudita 4
SN - Senegal 4
TN - Tunisia 4
BZ - Belize 3
EU - Europa 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
LY - Libia 3
NP - Nepal 3
RS - Serbia 3
SV - El Salvador 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BM - Bermuda 2
CU - Cuba 2
ET - Etiopia 2
GA - Gabon 2
NI - Nicaragua 2
NO - Norvegia 2
SI - Slovenia 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
Totale 11.770
Salva come PNG Salva come JPEG
Città #
Dublin 739
San Jose 595
Council Bluffs 347
Hong Kong 339
Singapore 335
Jacksonville 311
Ashburn 280
Columbus 172
Moscow 136
Beijing 132
Los Angeles 113
Ho Chi Minh City 110
Lauterbourg 105
Chandler 99
Phoenix 88
Hanoi 87
Lawrence 82
Princeton 82
New York 77
Santa Clara 77
Wilmington 72
San Mateo 69
Novara 64
Jakarta 55
Milan 55
Dearborn 54
Seoul 53
Munich 52
Piemonte 49
Dallas 48
Buffalo 47
Orem 44
Helsinki 43
Turin 43
Montreal 39
São Paulo 39
Dong Ket 36
Frankfurt am Main 34
Chennai 33
Cotonou 32
Philadelphia 29
Toronto 29
Bremen 27
Nuremberg 26
Rome 26
Ann Arbor 25
Denver 25
Vercelli 25
Brooklyn 24
Redondo Beach 24
Tokyo 23
Boardman 22
Chicago 22
Warsaw 22
Andover 21
Houston 21
London 21
Amsterdam 19
Brno 19
Boston 18
Johannesburg 18
Da Nang 17
Falkenstein 17
Mexico City 17
Atlanta 16
Norwalk 16
Stockholm 16
Vienna 16
North Bergen 15
Monmouth Junction 13
Poplar 13
Rio de Janeiro 13
Bologna 12
Haiphong 12
Hangzhou 12
Istanbul 12
Santiago 12
Augusta 11
Brasília 11
Dhaka 11
Guangzhou 11
Las Vegas 11
Seattle 11
Shanghai 11
The Bronx 11
Tianjin 11
West Jordan 11
Ankara 10
Charlotte 10
Guayaquil 10
Kocaeli 10
Mumbai 10
Naples 10
Paris 10
Schaumburg 10
The Dalles 10
Ardabil 9
Baghdad 9
Manchester 9
Miami 9
Totale 6.218
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 411
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 275
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 214
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 210
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 205
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 198
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 187
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 184
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 177
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 173
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 161
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 161
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 160
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 158
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 147
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 141
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 141
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 141
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 138
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 138
Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients 136
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 135
Chronic hepatitis C is mild in menstruating women 134
Adequate vs. deep response to UDCA in PBC: To what extent and under what conditions is normal ALP level associated with complication-free survival gain? 131
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 126
CYP2E1 autoantibodies in liver diseases 126
Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids 124
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 123
Giant liver fibrous tumours metastatic from atypical recurrent meningeal neoplasia 122
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years 121
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 121
Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study 119
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 119
Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome 116
Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C 116
Elastography in Liver-Transplanted Patients 116
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: Results from a 29-year cohort study 116
Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019 114
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 113
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 112
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients 112
Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study 110
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 109
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial 108
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 108
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis 106
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 105
Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C 103
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis 103
Authors’ response re: “The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs” 102
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes 101
Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C 100
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 97
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 95
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 95
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges 95
Severe thombocytopenia and clinical bleeding associated with rituximab infusion in a lynphoma patient with massive splenomegaly without leukemic invasion 93
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 92
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation 92
Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? Transient elastography makes it possible 91
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 91
The evolving landscape of autoimmune hepatitis: an ambispective cohort study 90
Gender and liver fibrosis in chronic hepatitis: the role of iron status 90
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 88
Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis 87
Transient elastography in the assessment of liver fibrosis in adult thalassemia patients 87
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients 86
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion 86
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 85
Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C 84
Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method 83
Transjugular liver biopsy: The Tru-cut needle might be better for stiffer livers 83
Do not trivialize the Fibroscan® examination, value its accuracy 82
SURVIVAL FOLLOWING THE DEVELOPMENT OF ASCITES AND/OR PERIPHERAL OEDEMA IN PRIMARY BILIARY CIRRHOSIS: A STAGED PROGNOSTIC MODEL 82
Dynamics of liver stiffness measurement and clinical course of primary biliary cholangitis 82
Spleen Stiffness Measured by Transient Elastography Accurately Predicts Esophageal Varices in Liver Cirrhosis 81
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy 80
Emerging Issues in the Immunopathogenesis, Diagnosis and Clinical Management of Primary Biliary Cirrhosis Associated with Systemic Sclerosis 80
Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk? 79
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C 79
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 79
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 77
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 76
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis 75
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C 75
High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy 75
Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy 74
ERCP and short-term stent-trial in patients with anastomotic biliary stricture following liver transplantation 74
Iron, hepatic stellate cells and fibrosis in chronic hepatitis C 73
Diagnosis of cirrhosis by transient elastography: what is hidden behind misleading results 72
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease 71
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation 70
Spleen stiffness in portal hypertension algorithms: the next advance 69
Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease 69
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation 69
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach 69
LIVER BIOPSY TECHNIQUES: AUTOMATED ASPIRATION NEEDLES PROVIDE ADEQUATE TISSUE SAMPLES 68
Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis 68
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study 67
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 67
Totale 11.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022470 0 0 0 44 38 17 43 20 60 37 82 129
2022/20231.418 155 84 70 19 69 87 56 60 718 19 48 33
2023/2024767 38 61 43 23 107 38 142 60 28 42 54 131
2024/20251.568 30 25 110 41 56 158 215 177 324 102 67 263
2025/20265.106 203 169 310 685 454 347 781 819 364 502 299 173
2026/20271.565 244 449 408 464 0 0 0 0 0 0 0 0
Totale 11.989